Svoronos Dawn
SEC insider (Form 3/4/5 filer). CIK 0001574579. Director at Xenon Pharmaceuticals Inc. (XENE) and 2 other issuers. 16 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in BURNABY.
Companies Svoronos Dawn has filed insider reports for
- Xenon Pharmaceuticals Inc. (XENE): Director
- Adverum Biotechnologies, Inc. (ADVM): Director
- ACELYRIN, Inc. (SLRN): Director
Svoronos Dawn
CIK: 0001574579
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Sep 1, 2026XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect5.1K shares at avg. $8.15$42K - Jun 3, 2026XENE
Xenon Pharmaceuticals Inc.
AwardDirectRestricted Share Units
1.6K shares- - Jun 3, 2026XENE
Xenon Pharmaceuticals Inc.
AwardDirectShare Option (Right to Buy)
10.5K shares- - Jun 1, 2026XENE
Xenon Pharmaceuticals Inc.
Tax PaymentDirect1.4K shares at avg. $53.41$76K - Jun 1, 2026XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect2.6K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
10.5K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
10.5K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
4K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
4.5K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 |  XENE Xenon Pharmaceuticals Inc. | Exercise | 5,144 | $8.15 | $41,924 | Direct |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | Award Restricted Share Units | 1,593 | - | - | Direct |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | Award Share Option (Right to Buy) | 10,507 | - | - | Direct |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc. | Tax Payment | 1,416 | $53.41 | $75,629 | Direct |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc. | Exercise | 2,645 | - | $0 | Direct |
| Dec 9, 2025 |  ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 10,520 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 10,450 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 4,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 4,500 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 4,000 | - | - | Direct |
1-10 of 16 transactions